Login to South West London Pathology Services

If you have any queries about pathology consumables – you need a new account or you have a query about your order, please telephone 020 8266 6827. Forgotten your password

SWLP Point of Care Manager speaks at international conference

This week, SWLP Point of Care Manager Haval Ozgun spoke at a virtual international point of care (POCT) conference, which was live-streamed to 35 European countries and then shared globally. Haval was interviewed by a TV broadcaster from Denmark about the role that POCT has played and is playing in the Covid-19 pandemic. Haval was asked questions about the challenges he and his team have faced during the pandemic, how they coped and what some of their successes have been.

One of the key challenges that Haval highlighted was the difficulty of identifying and isolating patientswith the virus before they became inpatients at the hospital. The solution required rapid testing capabilities, which were not available during the first wave of the pandemic, however new technology has now been successfully piloted at St George’s Hospital by the SWLP POCT team and is now being rolled out across the country. This is crucial because it prevents patients infecting staff and other patients while in hospital.

Haval also highlighted the value of the provision of blood gas analysers across the SWLP network as one of the big successes of the pandemic, noting that the harmonisation and standardisation project which was started in 2018 played a big part. Clinical staff in south west London were able to use the same platform for blood gas analysis, enhancing patient safety, service resilience and business continuity.

Haval says, “It was an honor to be able to speak at this event and to highlight all of the successes that we have seen in POCT.

“It is crucial now to keep innovation in POCT going as it saves lives. Testing is the first line of defense that we have in our health services and POCT is revolutionising how we manage our patients.”

Latest news

March 12, 2024

Beta D Glucan (BDG) testing brought in-house

At the end of last year, testing for Beta-D-Glucan (BDG) was brought in-house. The median turnaround time using the new in-house assay is around two days, which facilitates a greater impact on antifungal stewardship when the result is negative.

Read more
February 28, 2024

New Abbott Alinity system installed at Epsom Hospital

At the end of last year, a new Abbott Alinity GLP automation system was installed in the laboratory at Epsom Hospital, replacing the existing aging equipment.

Read more
February 7, 2024

Pathology Service Update: Results for renin, aldosterone, androstenedione, 17-hydroxyprogesterone, DHEAS and testosterone confirmation now going out at usual

The delay in reporting results for renin, aldosterone, androstenedione, 17-hydroxyprogesterone, DHEAS and testosterone confirmation reported in January has been resolved and results are now going out as usual.

Read more
January 29, 2024

Salmonella detection to be by PCR only from 1 February 2024

From 1 February 2024, Salmonella detection in faeces will be by PCR only and culture will no longer be routinely performed.

Read more